Product Information
Name:CPI-637
Brand:Biosynth
Description:CPI-637 is a potential drug for the treatment of prostate cancer. It is a small molecule that binds to the bromodomain, which is an important cellular protein that regulates transcriptional regulation. Bromodomains are found in many proteins and are known to be involved in many cellular processes and cancers. CPI-637 has been shown to inhibit the expression of genes associated with prostate cancer, HIV infection, and carcinogenesis. This agent does not bind to DNA but binds to histone h3 at a specific site called the response element-binding protein (RBP), which inhibits gene expression by binding to the RBP.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:386.45 g/mol
Formula:C22H22N6O
Purity:Min. 95%
Technical inquiry about: CPI-637
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.